Multiple Sclerosis - Biogen
As pioneers in neuroscience, Biogen has an innovative therapeutic pipeline that aims to reverse disability, repair damage, and address other remaining unmet needs in MS, with the goal of …
Relapsing MS Pill Treatments - Biogen Options
VUMERITY is a prescription medicine used to treat people with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active …
VUMERITY® (diroximel fumarate), an oral medication
VUMERITY is a prescription medicine used to treat people with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active …
Biogen Treatment Options for Relapsing MS
Biogen offers five approved treatments for relapsing MS. Learn more about each option to help you make an informed decision. Biogen Support Services can provide help with financial, …
Relapsing MS Infusion Treatment - Biogen Options
TYSABRI is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary …
Official Patient Website | Tecfidera® (dimethyl fumarate)
TECFIDERA ® (dimethyl fumarate) is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, …
The Evolving Field of MS Research | Biogen
2024年9月19日 · For more than 25 years Biogen has been a leader in the research and development of new medications for multiple sclerosis (MS). Our understanding of the disease …
AVONEX® (interferon beta-1a) | Official Patient Site
AVONEX is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary …
Relapsing MS Treatment | PLEGRIDY® (peginterferon beta-1a)
What is PLEGRIDY ® (peginterferon beta-1a)? PLEGRIDY is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, …
FDA approves Biogen's MS drug Plegridy | AP News - Associated …
2014年8月16日 · CAMBRIDGE, Mass. (AP) — Biogen Idec says that federal regulators have approved the specialty drugmaker’s new treatment for people with relapsing forms of multiple …